Childhood cancer survivors at risk for subsequent neoplasms later in life
the ONA take:
Survivors of childhood cancer remain at increased risk for treatment-related subsequent neoplasms, even after the age of 40, according to a new study published online ahead of print in the Journal of Clinical Oncology.
Previous research has shown that survivors of childhood cancer have an increased risk for subsequent neoplasms, but there is limited evidence demonstrating the risk after age 40.
For the study, researchers analyzed data from 14,364 childhood cancer survivors diagnosed between 1970 and 1986. Of those, 3,171 had reached age 40 or older at the time of last contact.
Results showed that 679 subsequent neoplasms were diagnosed in patients 40 years of age and older. Of those, 196 were subsequent malignant neoplasms, 419 were nonmelanoma skin cancers, 21 were nonmalignant meningiomas, and 43 were other benign neoplasms.
Researchers found that survivors were more than twice as likely to develop a subsequent neoplasm after the age of 40 compared with the general population.
Specifically, childhood cancer survivors had a higher risk for breast cancer, renal cancer, soft tissue sarcoma, and thyroid cancer. Being a female and having underwent radiation were associated with an increased risk for subsequent neoplasms after age 40, as well.
The findings suggest that childhood cancer survivors should be monitored for subsequent cancers for their lifetime.
Survivors of childhood cancer remain at increased risk for treatment-related subsequent neoplasms, even after the age of 40.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Patients and Caregivers Worry About Cost of Cancer Care
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|